Having trouble accessing articles? Reset your cache.

Rituxan regulatory update

The U.K.'s NICE issued guidance recommending use of Roche's MabThera rituximab in combination with fludarabine and cyclophosphamide

Read the full 174 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE